本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

CALIDI BIOTHERAPEUTICS INC

0.2458
+0.01195.09%
盘后0.25440.0086+3.50%16:59 EDT
成交量:55.11万
成交额:13.33万
市值:781.46万
市盈率:-0.08
高:0.2500
开:0.2339
低:0.2339
收:0.2339
数据加载中...
2024/01/08

SEC问询函

Form CORRESP - Correspondence
2024/01/08

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/05

重要事件披露

Form 8-K - Current report
2023/12/19

重要事件披露

Form 8-K - Current report
2023/12/12

SEC问询函

Form CORRESP - Correspondence
2023/12/12

重要事件披露

Form 8-K - Current report
2023/12/12

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/12/05

重要事件披露

Form 8-K - Current report
2023/11/15

重要事件披露

Form 8-K - Current report
2023/11/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/30

重要事件披露

Form 8-K - Current report
2023/10/28

重要事件披露

Form 8-K - Current report
2023/10/25

重要事件披露

Form 8-K/A - Current report: [Amend]
2023/10/16

重要事件披露

Form 8-K - Current report
2023/10/10

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/10/06

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2023/09/30

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/09/26

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/09/26

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership